Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Apremilast in Pruritus: NCT07432386 Clinical Landscape Report 2026
28 September 2026
NCT07432386 clinical landscape for Pruritus: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Escitalopram Oxalate in Depressive Disorder: NCT07432815 Clinical Landscape Report 2026
28 September 2026
NCT07432815 clinical landscape for Depressive Disorder: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Universal CLL1 CAR-T cells(Tianjin First Central Hospital) in Relapsing acute myeloid leukemia: NCT07432100 Clinical Landscape Report 2026
28 September 2026
NCT07432100 clinical landscape for Relapsing acute myeloid leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white spac…
9 min read
Eganelisib in Acute Myeloid Leukemia: NCT07439211 Clinical Landscape Report 2026
28 September 2026
NCT07439211 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Selinexor in Acute Myeloid Leukemia: NCT07437170 Clinical Landscape Report 2026
28 September 2026
NCT07437170 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Tacrolimus in Dermatitis, Atopic: NCT07437534 Clinical Landscape Report 2026
28 September 2026
NCT07437534 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
CT1390B in Relapsing acute myeloid leukemia: NCT07441980 Clinical Landscape Report 2026
28 September 2026
NCT07441980 clinical landscape for Relapsing acute myeloid leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white spac…
9 min read
Crisaborole in Dermatitis, Atopic: NCT07438509 Clinical Landscape Report 2026
28 September 2026
NCT07438509 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Decitabine/Cedazuridine in Acute Myeloid Leukemia: NCT07437950 Clinical Landscape Report 2026
28 September 2026
NCT07437950 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Voriconazole in Acute Myeloid Leukemia: TCTR20260301004 Clinical Landscape Report 2026
28 September 2026
TCTR20260301004 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Tirzepatide in Arthritis, Psoriatic: NCT07443956 Clinical Landscape Report 2026
28 September 2026
NCT07443956 clinical landscape for Arthritis, Psoriatic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Soquelitinib in Eczema: NCT07441395 Clinical Landscape Report 2026
28 September 2026
NCT07441395 clinical landscape for Eczema: endpoints, sponsor, phase, geography, readouts, asset context and development white space.